Bradykinin antagonists: new opportunities

被引：50

作者：

Bock, MG ^{[1
]}

Longmore, J

机构：

[1] Merck Res Labs, W Point, PA 19486 USA

[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2000年 / 4卷 / 04期

关键词：

D O I：

10.1016/S1367-5931(00)00107-1

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The pro-inflammatory, pain producing, and cardiovascular effects of bradykinin B-2 receptor activation are well characterized. Bradykinin B-1 receptors also produce inflammation and pain. Therefore, antagonists are expected to be anti-inflammatory/analgesic drugs. Other exploitable clinical opportunities may exist. The newly discovered non-peptide B-2 receptor antagonists and the equivalent B-1 receptor pharmacological agents, which are in the pipeline, are suitable preclinical tools to properly evaluate potential utilities.

引用

页码：401 / 406

页数：6

共 50 条

[41] New bradykinin antagonists -: influence of the C-terminal modifications on their pharmacological properties
Sleszynska, Malgorzata
Kwiatkowska, Anna
Sobolewski, Dariusz
Slaninova, Jirina
Wierzba, Tomasz
Lammek, Bernard
Prahl, Adam
JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 84 - 84
[42] RECEPTOR ANTAGONISTS OF BRADYKININ - A NEW TOOL TO STUDY THE CARDIOVASCULAR EFFECTS OF ENDOGENOUS KININS
MADEDDU, P
PHARMACOLOGICAL RESEARCH, 1993, 28 (02) : 107 - 128
[43] Similarity studies on guanidinium, imidazolinium, and imidazolium cations: Toward new bradykinin antagonists
Dardonville, C
Rozas, I
Alkorta, I
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1998, 16 (03): : 150 - +
[44] New bradykinin antagonists having very high potency at B(1)receptors
Gera, L
Stewart, JM
Whalley, ET
Burkard, M
Zuzack, JS
IMMUNOPHARMACOLOGY, 1996, 33 (1-3): : 183 - 185
[45] Bradykinin-1 receptor antagonists
Bock, MG
Hess, JF
Pettibone, DJ
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 111 - 120
[46] New highly potent peptide bradykinin B-1 receptor antagonists
Gera, L.
Stewart, J. M.
Fortin, J. -P.
Marceau, F.
JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 211 - 211
[47] A NEW CLASS OF BRADYKININ ANTAGONISTS - SYNTHESIS AND INVITRO ACTIVITY OF BISSUCCINIMIDOALKANE PEPTIDE DIMERS
CHERONIS, JC
WHALLEY, ET
NGUYEN, KT
EUBANKS, SR
ALLEN, LG
DUGGAN, MJ
LOY, SD
BONHAM, KA
BLODGETT, JK
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (09) : 1563 - 1572
[48] LUMINAL RESPONSES TO BRADYKININ ON THE ISOLATED CANINE TRACHEAL EPITHELIUM - EFFECTS OF BRADYKININ ANTAGONISTS
RANGACHARI, PK
DONOFF, B
VAVREK, RJ
STEWART, JM
REGULATORY PEPTIDES, 1990, 30 (03) : 221 - 230
[49] NEW POTENT B2 BRADYKININ ANTAGONISTS ACYLATED ON THEIR N-TERMINALS
Dawidowska, O.
Prahl, A.
Kowalczyk, W.
Derdowska, I.
Slaninova, J.
Wierzba, T.
Lammek, B.
JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 241 - 241
[50] New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding
Lupala, Cecylia S.
Gomez-Gutierrez, Patricia
Perez, Juan J.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2016, 30 (01) : 85 - 101

← 1 2 3 4 5 →